Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dna Repair and Damage Pathways in Mesothelioma Development and Therapy Publisher



Malakoti F1 ; Targhazeh N1 ; Abadifard E2, 3 ; Zarezadeh R1 ; Samemaleki S4 ; Asemi Z5 ; Younesi S6 ; Mohammadnejad R1 ; Hadi Hossini S1 ; Karimian A7 ; Alemi F1 ; Yousefi B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  5. 5. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
  6. 6. Schoole of Health and Biomedical Sciences, RMIT University, Melbourne, Vic, Australia
  7. 7. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

Source: Cancer Cell International Published:2022


Abstract

Malignant mesothelioma (MMe) is an aggressive neoplasm that occurs through the transformation of mesothelial cells. Asbestos exposure is the main risk factor for MMe carcinogenesis. Other important etiologies for MMe development include DNA damage, over-activation of survival signaling pathways, and failure of DNA damage response (DDR). In this review article, first, we will describe the most important signaling pathways that contribute to MMe development and their interaction with DDR. Then, the contribution of DDR failure in MMe progression will be discussed. Finally, we will review the latest MMe therapeutic strategies that target the DDR pathway. © 2022, The Author(s).